SF

Shinichiro Fuse

Partner/Managing Director at TPG Life Sciences Innovation

Cambridge, Massachusetts

Advisor

Invests in

  • Min Investment:

    $0.00

  • Max Investment:

    $0.00

  • Target Investment:

    $0.00

Skills

Biotechnology Industry
Lifesciences
Data Analysis
Business Strategy
Financial Modeling
Science
Entrepreneurship
Biotechnology
Assay Development
Start-ups
Strategy
Vaccines
Business Development
Leadership
Pharmaceutical Industry
Immunology
Oncology
Consulting
Life Sciences
Molecular Biology

Education

Investments

Sudo Biosciences

Series B

Total Funding: $180M

Santa Ana Bio

Series A

Total Funding: $170M

Orna Therapeutics

Seed

Total Funding: $320M

Triplet Therapeutics

Series A

Total Funding: $49M

Work Experience

TPG

2021

  • Partner/Managing Director

    2021

    Partner/Co-Lead, Life Sciences Innovations (LSI) Fund. Investments: Santa Ana Bio (Board), Sudo Biosciences (Board).

Orna Therapeutics, Inc.

2019 - 2021

  • Board Member

    2020 - 2021

  • Interim CEO / Board Member

    2019 - 2020

    Circular RNA newco, MIT spinout (fka Oroboros)

ElevateBio

2017 - 2021

  • Advisor

    2019 - 2021

    Board observer

  • Founding/Interim Senior Vice President, Business Development

    2017 - 2019

    Led BD for ElevateBio (MPM newco) from launch - BD strategy, deal sourcing, diligence, transactions, establishment of Elevate subsidiaries, alliance management. Launched newcos/deals include AlloVir (fka Viracyte), HighPassBio, and other stealth newco's. Supported initial LifeEdit negotiations.

MPM Capital

2016 - 2021

  • Managing Director

    2018 - 2021

    Life science venture capital & newco building. Investments: Orna (board + interim CEO), Triplet Therapeutics (board), ElevateBio (board observer), AlloVir (NASDAQ: ALVR), Repare Therapeutics (RPTX, board observer til IPO), CODA Biotherapeutics (board observer), iTeos Therapeutics (ITOS), 28-7, iOmx Therapeutics (board, starting 06/2020-), Crossbow

  • Principal

    2016 - 2018

bluebird bio

2014 - 2016

  • Director, Business Development

    2015 - 2016

    Deal sourcing, diligence, negotiations, alliance management, strategy, and competitive intelligence. Lead/support on academic/corporate licenses/options, sponsored research, and M&A (Pregenen).

  • Senior Manager, Business Development

    2014 - 2015

Campbell Alliance

2012 - 2014

  • Engagement Manager

    2013 - 2014

    Corporate Development team: Business development, corporate strategy, valuation, revenue forecasting, launch planning, indication prioritization.

  • Senior Consultant

    2012 - 2013

PureTech Ventures

2011 - 2012

  • Associate

    2011 - 2012

    Founding & operational team of Vedanta Biosciences (microbiome) and Mandara Sciences (nutrition). Technology sourcing, due diligence, deal support, and newco building.

Clarion Healthcare

2008 - 2011

  • Consultant

    2009 - 2011

    Healthcare strategy consulting, primarily in oncology and immunology. Business development, corporate strategy, revenue forecasting, sales operations, launch planning.

  • Associate Consultant

    2008 - 2009

Morgan Stanley

2007 - 2007

  • Summer Associate

    2007 - 2007

    Institutional Equities Division (Equity Research, Equity Sales & Trading). Industry and company analysis.